Tag: Liver Disease: Misc.
Bariatric-Metabolic Surgery Effective for Nonalcoholic Steatohepatitis Treatment
Bariatric-metabolic surgery more effective than lifestyle modification plus best medical care
Breakthrough SARS-CoV-2 Similar for Chronic Liver Disease With, Without Cirrhosis
However, full vaccination associated with two-thirds lower risk for death with cirrhosis
Nonalcoholic Fatty Liver Disease Improved With Exercise
Clinically meaningful treatment response occurs independently of weight loss
Intermittent Fasting Plus Exercise Aids Hepatic Steatosis
Among patients with obesity and nonalcoholic fatty liver disease, benefits seen for weight, insulin sensitivity, and liver enzymes
Hospital Volume Affects Liver Surgery Outcomes
Rates of in-hospital mortality, failure to rescue decreased from a hospital volume threshold of >25 liver resections per year
Fast-Food Consumption Linked to Liver Steatosis
Fast-food intake ≥20 percent of daily calories linked to greater steatosis as continuous measure and with the CAP ≥263 dB/m cutoff
Epstein-Barr Viral Load Monitoring May Reduce Risk After Liver Transplant
Epstein-Barr virus viral load monitoring may reduce incidence of posttransplant lymphoproliferative disease
~10 Percent of Psoriasis Patients Have High Risk for Liver Fibrosis
Increased odds ratios seen for advanced liver fibrosis with age older than 50 years, BMI >30, diabetes, hypertension, dyslipidemia, metabolic syndrome
Bariatric Surgery Cuts CVD Risk in Patients With Obesity, NAFLD
Findings seen versus nonsurgical care among individuals with severe obesity and nonalcoholic fatty liver disease
Risk for Advanced Fibrosis Examined for Relatives of NAFLD Patients
Age 50 years or older, male sex, diabetes mellitus, first-degree relative with NAFLD with advanced fibrosis predict advanced fibrosis
